Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
Omega-3 polyunsaturated fatty acids
Potential treatment - clinical evidence Natural product Unknown Mar/29/2021
Mahuang Liu Jun Tang
Potential treatment - clinical evidence Natural product Unknown Sep/14/2020
Hanshiyi Formula
Potential treatment - clinical evidence Natural product Unknown Aug/13/2020
Ambroxol
Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021
Thapsigargin
Potential treatment - pre-clinical evidence Natural product Other treatment Feb/03/2021
NRICM101
Potential treatment - clinical evidence Natural product Other treatment Nov/19/2020
Vitamin B12
Potential treatment - clinical evidence Natural product Other treatment Aug/18/2020
Coronil
Potential treatment - pre-clinical evidence Natural product Other treatment Nov/02/2020
Lianhua Qingwen
Recommended by China's NHC Guidelines Natural product Other treatment Jan/29/2021
Ascorbic acid
Potential treatment - clinical evidence Natural product Other treatment Feb/26/2021
Xue Bi Jing
Potential treatment - clinical evidence Natural product Other treatment Sep/10/2020
mmu-miR-200c
Potential treatment - theoretical effect Natural product Other treatment Sep/03/2020
Cytochalasin D
Potential treatment - theoretical effect Natural product Other treatment Jun/27/2020
Prostratin
Potential treatment - theoretical effect Natural product Other treatment Jun/27/2020
Shufeng Jiedu
Potential treatment - clinical evidence Natural product Other treatment Oct/22/2020
Tannic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/30/2021
17-alpha-Hydroxywithanolide D
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
Antipain
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021
Withanolide R
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
rlcv-miR-rL1-28-3p
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021